(-)-desmethylsibutramine

（-）-去甲基西布曲明

Report date: 2022/03/09 15:08:49

Base Information

Drug Name(-)-desmethylsibutramine
Drug Alias Name(-)-sibutramine metabolite(-)-Didesmethylsibutramine(-)-DDMS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsSerotonin transporterDopamine transporterNorepinephrine transporter
Therapy Area/IndicationsUrinary Incontinence, StressErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence, StressErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksWikipedia